Our Startups
We have invested in 100+ companies across all industries and are growing.
We have invested in 100+ companies across all industries and are growing.
Xilis is generating a new category of patient data designed to inform and improve both drug discovery and treatment selection. Their proprietary MicroOrganoSphere (MOS) technology generates thousands of miniature patient-derived tumors that capture the original heterogeneity and microenvironment for therapeutic profiling.
